Quebec, Canada

Nicolas Bertrand

This inventor holds 1 USPTO granted patent. Top assignee: Universitè Laval. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nicolas Bertrand. Retrieved from https://idiyas.com/inventor/nicolas-bertrand-ghxaneal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Nicolas Bertrand and Polymer-Based Drug Delivery

Introduction

Nicolas Bertrand is an inventor associated with Université Laval in Quebec, Canada. His work includes research into polymer materials and their potential applications in delivering bioactive agents.

Latest Patents

Bertrand is associated with 1 patent: “Monoglycerol Acrylate Based Polymer and Uses Thereof.” The invention concerns amphiphilic poly(monoglycerol acrylate) polymers, which combine hydrophilic monoglycerol acrylate repeating units with one or more biodegradable hydrophobic groups. It describes their use in delivering bioactive agents, methods for using them, and a method for preparing the polymers.

Career Highlights

The patent reflects Bertrand’s involvement in developing biodegradable polymer systems for bioactive-agent delivery. The disclosed approach brings together polymer design and preparation methods with potential applications in delivery technologies.

Collaborations

Bertrand’s listed coworkers include Sabrina Roussel and Philippe Grenier. The patent information also associates his work with Université Laval.

Conclusion

Nicolas Bertrand’s patent work focuses on monoglycerol acrylate-based polymers and their potential role in delivering bioactive agents.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…